Yohei Arai1, Eiichiro Kanda2,3, Soichiro Iimori1, Shotaro Naito1, Yumi Noda4, Sei Sasaki1, Eisei Sohara1, Tomokazu Okado1, Tatemitsu Rai1, Shinichi Uchida1. 1. Department of Nephrology, Tokyo Medical and Dental University, Tokyo, Japan. 2. Department of Nephrology, Tokyo Medical and Dental University, Tokyo, Japan. tokyo.kyosai.kanda@gmail.com. 3. Department of Nephrology, Tokyo Kyosai Hospital, 2-3-8 Nakameguro, Meguroku, Tokyo, 153-8934, Japan. tokyo.kyosai.kanda@gmail.com. 4. Department of Nephrology, Nitobe Memorial Nakano General Hospital, Tokyo, Japan.
Abstract
BACKGROUND: Elevated white blood cell (WBC) count is a well-known predictor of chronic kidney disease (CKD) progression. However, elderly patients commonly fail to develop a high WBC count in response to several diseased states and may instead present a low WBC count. Therefore, we hypothesized that low WBC count, in addition to high WBC count, is associated with CKD progression in the elderly. METHODS: We conducted a prospective cohort study using 3-year follow-up data from the CKD Research of Outcomes in Treatment and Epidemiology study. In the present study, participants aged over 60 years with pre-dialysis CKD stages G2-G5 were eligible. Patients were stratified into three groups according to WBC count using tertiles (T). The primary outcome was a composite of end-stage renal disease and a 50% reduction in estimated glomerular filtration rate. Data were analyzed using Cox proportional hazard models with adjustments for covariates. RESULTS: We enrolled 697 patients (males, 69%). The median WBC count was 6100 cells/µl (T1, <5400, n = 222; T2, 5400-6900, n = 235; T3, ≥6900, n = 240). During a median follow-up of 868 days, the primary outcome was observed in 170 patients, whereas 54 patients died. T1 and T3 had significantly higher hazard ratios (HR) than T2 (T1, HR 1.69, 95% confidence interval 1.14-2.51; T3, HR 1.63, 95% confidence interval 1.10-2.41). Moreover, T1 had a significantly higher adjusted HR (1.54, 95% confidence interval 1.00-2.37). CONCLUSION: Low WBC count is independently associated with CKD progression in the elderly.
BACKGROUND: Elevated white blood cell (WBC) count is a well-known predictor of chronic kidney disease (CKD) progression. However, elderly patients commonly fail to develop a high WBC count in response to several diseased states and may instead present a low WBC count. Therefore, we hypothesized that low WBC count, in addition to high WBC count, is associated with CKD progression in the elderly. METHODS: We conducted a prospective cohort study using 3-year follow-up data from the CKD Research of Outcomes in Treatment and Epidemiology study. In the present study, participants aged over 60 years with pre-dialysis CKD stages G2-G5 were eligible. Patients were stratified into three groups according to WBC count using tertiles (T). The primary outcome was a composite of end-stage renal disease and a 50% reduction in estimated glomerular filtration rate. Data were analyzed using Cox proportional hazard models with adjustments for covariates. RESULTS: We enrolled 697 patients (males, 69%). The median WBC count was 6100 cells/µl (T1, <5400, n = 222; T2, 5400-6900, n = 235; T3, ≥6900, n = 240). During a median follow-up of 868 days, the primary outcome was observed in 170 patients, whereas 54 patients died. T1 and T3 had significantly higher hazard ratios (HR) than T2 (T1, HR 1.69, 95% confidence interval 1.14-2.51; T3, HR 1.63, 95% confidence interval 1.10-2.41). Moreover, T1 had a significantly higher adjusted HR (1.54, 95% confidence interval 1.00-2.37). CONCLUSION: Low WBC count is independently associated with CKD progression in the elderly.
Entities:
Keywords:
Bone marrow dysfunction; Chronic kidney disease; End-stage renal disease; Inflammation; Malnutrition; White blood cell count
Authors: Arianne van Koppen; Jaap A Joles; Lennart G Bongartz; Jens van den Brandt; Holger M Reichardt; Roel Goldschmeding; Tri Q Nguyen; Marianne C Verhaar Journal: Cell Transplant Date: 2012 Impact factor: 4.064
Authors: Stephanie K Bunt; Ashley M Mohr; Jennifer M Bailey; Paul M Grandgenett; Michael A Hollingsworth Journal: Cancer Immunol Immunother Date: 2012-08-05 Impact factor: 6.968